Here’s why the Mach7 (ASX:M7T) share price just reached a multi-year high

The Mach7 Technologies Ltd (ASX: M7T) share price is soaring today after the company announced an amended contract with Adventist Health.
The post Here’s why the Mach7 (ASX:M7T) share price just reached a multi-year high appeared first on The Motley Fool Australia. –

asx medical share price represented by x-ray or people shaking hands

The Mach7 Technologies Ltd (ASX: M7T) share price reached a multi-year high today. This comes after the company announced it has altered an existing contract with Adventist Health System.

During morning trade, the Mach7 share price stormed higher to $1.47, representing a new, multi-year high. At the time of writing, Mach7 shares have slightly pulled back to $1.45, up 9.85%. In comparison, the All Ordinaries Index (ASX: XAO) is marginally higher to 7,097 points, up 0.3%.

What’s driving the Mach7 share price?

The Mach7 share price is on the move after the company reported it has expanded its relationship with Adventist Health.

According to the release, Mach7 will provide Adventist Health the licence for its Mach7 Picture Archive Communication System (PACS) solution. This includes the Mach7 Enterprise Imaging Platform, eUnity Diagnostic Viewer, Mach7 Universal Worklist, Mach7 QC Module, and Mach7 Clinical Portal.

Terms of the deal

Under the agreement, the software licence will be rolled out in stages as per Adventist Health’s individual hospital directions. Mach7 is anticipating that 3 of the 22 hospitals will place an order within the current quarter, reflecting immediate short-term revenue generation.

The remaining orders are mostly expected to be completed by the end of the 2021 calendar year.

The contract is worth $7.9 million, and includes migration services as well as support and maintenance for 5 years.

Quick take on Adventist Health

Adventist Health is a multinational, non-profit corporation that services over 80 communities across the West Coast of the United States, and in Hawaii. The organisation provides care in hospitals, clinics, home care agencies, hospice agencies and joint-venture retirement centres.

Management commentary

Mach7 CEO Mr Mike Lampron welcomed the extended partnership, saying:

I am delighted to partner with Adventist for their PACS replacement project. The collaborative partnership we have established with Adventist Health has allowed us to help them expand their enterprise imaging growth strategy. I am confident Mach7’s full Enterprise PACS solution will provide a flexible and scalable foundation that meets the needs of radiologists across their health network.

Mach7 share price snapshot

The Mach7 share price has travelled higher over the last 12 months, gaining almost 90%.

Its shares reached a 52-week low of 37 cents in March, before rising to a multi-year high of $1.47 today.

Based on the current Mach7 share price, the company commands a market capitalisation of roughly $340 million.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of June 30th

More reading

Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MACH7 FPO. The Motley Fool Australia has recommended MACH7 FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Here’s why the Mach7 (ASX:M7T) share price just reached a multi-year high appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!